Lilly Announces a Call for Articles Into 2007 Luminous Award
Indianapolis (ots/PRNewswire)
- Luminous Award recognizes outstanding cancer journalism from outlets around the world
Following the success of the inaugural Luminous Award in 2006, Lilly Oncology announced today the call for entries to Luminous 2007. The Luminous Award was created by Lilly to honour journalism that serves readers and viewers by providing responsible, accurate and timely information on advances in cancer prevention, research, development and treatment.
Open to all journalists reporting for newspapers, consumer magazines, newsletters, websites and broadcast outlets, entries are judged on a series of criteria including news value, the ability to stimulate awareness about advances in oncology, effective communication for the intended audience and creativity. The closing deadline for entries is 1 September 2007, and the winner will be announced during the European Conference on Clinical Oncology (ECCO), 23 - 27 September 2007.
The winner of the Luminous Award will have the opportunity to choose a seven-day trip for two people to Boston, London, New York, Paris or Sydney, to be enlightened by the work of a world-renowned oncologist or cancer researcher.
As an alternative to the trip, the winner may choose a cash donation of euro 10,000 made in the form of a scholarship, in their name, to help a student continue his or her studies to become a journalist and enlighten others through his or her work.
There will also be a runner-up prize of five days for two to either London or New York where he or she will have the opportunity to meet with a world-renowned oncologist or cancer researcher who will share their insights. Alternatively, the runner-up may select a cash donation of euro 5,000 made in the form of a scholarship, in their name, to help a student continue his or her studies to become a journalist and enlighten others through his or her work.
Certain local restrictions may apply regarding this Journalism Award and it is only available where not prohibited or restricted by local laws and regulations.
For further information and an entry form, please contact:
Gina Worthington Christine Van Marter
Luminous Award Secretariat Eli Lilly and Company
Tel: +44-207-395-7180 Tel: +1-317-651-1473
Fax: +44-207-395-7101 Email: vanmarterch@lilly.com
E-mail: luminousaward@cprworldwide.comAbout Lilly Oncology, a Division of Eli Lilly and Company
For more than four decades, Lilly Oncology has been collaborating with cancer researchers to deliver innovative treatment choices and valuable programs to patients and physicians worldwide. Inspired by the courageous patients living with cancer, Lilly Oncology is providing treatments that are considered global standards of care and developing a broad portfolio of novel targeted therapies to accelerate the pace and progress of cancer care.
About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs.
O-LLY
(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO http://www.newscom.com/cgi-bin/prnh/20070601/CLF003LOGO )
Contact:
Christine Van Marter, of Eli Lilly and Company, +1-317-651-1473,
CHRISTINE_VAN_MARTER@lilly.com . NewsCom:
http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO,
http://www.newscom.com/cgi-bin/prnh/20070601/CLF003LOGO , PRN Photo
Desk, photodesk@prnewswire.com